Terminology Service for NFDI4Health
All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| L-dopa | CHEBI_15765 | [An optically active form of dopa having L-configuration. Used to treat the stiffness, tremors, spasms, and poor muscle control of Parkinson's disease] |
| dopa | CHEBI_49168 | [A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.] |
| L-dopa(1-) | CHEBI_67012 | [A L-alpha-amino acid anion which is the conjugate base of L-dopa, obtained by deprotonation of the carboxy group: major species at pH 7.3.] |
| L-dopa zwitterion | CHEBI_57504 | |
| dopaminergic agent | CHEBI_48560 | [A drug used for its effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.] |
| D-dopa | CHEBI_49169 | [The D-enantiomer of dopa.] |
| stigmastane derivative | CHEBI_131702 | [Any steroid (or derivative) based on a stigmastane skeleton.] |
| N-benzoyl-D-arginine-4-nitroanilide | CHEBI_15766 | [The 4-nitroanilide of N-benzoyl-D-arginine.] |
| N-benzoyl-D-argininium-4-nitroanilide(1+) | CHEBI_57505 | [Conjugate acid of N-benzoyl-D-arginine-4-nitroanilide arsing from protonation of the side-chain guanidine function of the arginine residue.] |
| stigmastane sterol | CHEBI_131703 | [Any sterol based on a stigmastane skeleton.] |
| 4-fluoro-N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide | CHEBI_106710 | |
| S-(1-hydroxy-2-oxopropyl)-L-cysteine residue | CHEBI_131710 | [An L-alpha-amino acid residue derived from S-(1-hydroxy-2-oxopropyl)-L-cysteine.] |
| CHEBI_40717 | CHEBI_40717 | |
| L-2-amino-4-methoxy-cis-but-3-enoic acid | CHEBI_40719 | |
| L-alpha-aminobutyric acid | CHEBI_35619 | [An optically active form of alpha-aminobutyric acid having L-configuration.] |
| 1-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea | CHEBI_106715 | |
| (2S,3R)-3-(4-hydroxyphenyl)-2-(4-{[(2R)-2-pyrrolidin-1-ylpropyl]oxy}phenyl)-2,3-dihydro-1,4-benzothiin-6-ol | CHEBI_40713 | |
| benzoxathiin | CHEBI_46671 | |
| N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclohexanecarboxamide | CHEBI_106716 | |
| CHEBI_40714 | CHEBI_40714 |